Witnessing the stock’s movement on the chart, on Thursday, Caris Life Sciences Inc (NASDAQ: CAI) set off with pace as it heaved 8.70% to $38.12, before settling in for the price of $35.07 at the close. Taking a more long-term approach, CAI posted a 52-week range of $25.40-$39.80.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Nevertheless, stock’s Earnings Per Share (EPS) this year is 19.50%. This publicly-traded company’s shares outstanding now amounts to $281.22 million, simultaneously with a float of $114.28 million. The organization now has a market capitalization sitting at $10.72 billion.
Caris Life Sciences Inc (CAI) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Caris Life Sciences Inc’s current insider ownership accounts for 48.50%, in contrast to 10.20% institutional ownership. According to the most recent insider trade that took place on Jun 20 ’25, this organization’s insider bought 7,500 shares at the rate of 21.00, making the entire transaction reach 157,500 in total value, affecting insider ownership by 123,591. Preceding that transaction, on Jun 20 ’25, Company’s insider bought 30,000 for 21.00, making the whole transaction’s value amount to 630,000. This particular insider is now the holder of 162,428 in total.
Caris Life Sciences Inc (CAI) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.02 per share during the current fiscal year.
Caris Life Sciences Inc’s EPS increase for this current 12-month fiscal period is 19.50% and is forecasted to reach 0.26 in the upcoming year.
Caris Life Sciences Inc (NASDAQ: CAI) Trading Performance Indicators
Let’s observe the current performance indicators for Caris Life Sciences Inc (CAI). It’s Quick Ratio in the last reported quarter now stands at 8.60. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 20.08.
In the same vein, CAI’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -18.57, a figure that is expected to reach -0.14 in the next quarter, and analysts are predicting that it will be 0.26 at the market close of one year from today.
Technical Analysis of Caris Life Sciences Inc (CAI)
Going through the that latest performance of [Caris Life Sciences Inc, CAI]. Its last 5-days volume of 0.78 million was inferior to the volume of 0.83 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 74.47% While, its Average True Range was 70.90%.
